Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5094810
Max Phase: Preclinical
Molecular Formula: C82H110N16O22
Molecular Weight: 1671.87
Molecule Type: Unknown
Associated Items:
ID: ALA5094810
Max Phase: Preclinical
Molecular Formula: C82H110N16O22
Molecular Weight: 1671.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C82H110N16O22/c1-40(2)32-58(74(112)86-43(7)71(109)90-62(78(116)96-66(41(3)4)70(83)108)36-50-38-85-55-23-17-15-21-53(50)55)91-75(113)59(34-48-24-26-51(103)27-25-48)92-73(111)57(29-31-65(106)107)88-72(110)56(28-30-64(104)105)89-76(114)61(35-49-37-84-54-22-16-14-20-52(49)54)93-79(117)63(39-99)95-81(119)69(45(9)101)98-77(115)60(33-47-18-12-11-13-19-47)94-80(118)67(42(5)6)97-82(120)68(44(8)100)87-46(10)102/h11-27,37-38,40-45,56-63,66-69,84-85,99-101,103H,28-36,39H2,1-10H3,(H2,83,108)(H,86,112)(H,87,102)(H,88,110)(H,89,114)(H,90,109)(H,91,113)(H,92,111)(H,93,117)(H,94,118)(H,95,119)(H,96,116)(H,97,120)(H,98,115)(H,104,105)(H,106,107)/t43-,44+,45+,56-,57-,58-,59-,60-,61-,62-,63-,66-,67-,68-,69-/m0/s1
Standard InChI Key: HJHDJDLGLAAFHR-CNKFITJPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1671.87 | Molecular Weight (Monoisotopic): 1670.7981 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bourbiaux K, Legrand B, Verdié P, Mallart S, Manette G, Minoletti C, Stepp JD, Prigent P, Le Bail JC, Gauzy-Lazo L, Duclos O, Martinez J, Amblard M.. (2021) Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9., 64 (15.0): [PMID:34266235] [10.1021/acs.jmedchem.0c02051] |
Source(1):